Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Prepping a case for canakinumab, Novartis tries to stake out a high-value segment of huge cardio market
Prepping a case for canakinumab, Novartis tries to stake out a high-value segment of huge cardio market
Prepping a case for canakinumab, Novartis tries to stake out a high-value segment of huge cardio market
Submitted by
admin
on November 13, 2017 - 8:51pm
Source:
Endpoints
News Tags:
Novartis
canakinumab
heart disease
heart attack
Headline:
Prepping a case for canakinumab, Novartis tries to stake out a high-value segment of huge cardio market
Do Not Allow Advertisers to Use My Personal information
